Drug Description in Trials / DrugBank / KEGG DRUG
Search results
| No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
|---|---|---|---|---|---|---|
| 1 | (RS)-baclofen, naltrexone hydrochloride and D-sorbitol | [3] Baclofen Baclofen,Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release), Sorbitol | [4] D00096
D00096
,D00241 , D02095 (Name: Naltrexone hydrochloride), D05113 | [5] GABBR1 GABBR1,GABBR2, OPRD1, OPRK1, OPRM1 💬 | [9] Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 10 10 |
| 2 | 4.5 mg Naltrexone (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 13 13 |
| 3 | Low dose naltrexone (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 |
| 4 | Low-dose naltrexone (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 226 226 |
| 5 | Naltrexone (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 |
| 6 | NALTREXONE CLORIDRATO (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 10 10 |
| 7 | NALTREXONE HYDROCHLORIDE | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [8] 10 10, 40, 41, 42, 43, 44, 45, 96 |
| 8 | Naltrexone-HCl (Synonym: Naltrexone hydrochloride) | [1] Naltrexone Naltrexone (Synonym: Naltrexone Hydrochloride and Bupropion Hydrochloride Extended-Release) | [2] D02095
D02095
(Name: Naltrexone hydrochloride),D05113 | [3] OPRD1 OPRD1,OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 96 96 |